- Investing Ideas
- Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Belgian Pharmaceuticals & Biotech Big Green Snowflakes
Results
7
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
7 companies
argenx
Market Cap: €53.5b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€870.00
7D
16.2%
1Y
55.6%
UCB
Market Cap: €41.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€217.30
7D
-3.9%
1Y
12.9%
Celyad Oncology
Market Cap: €12.5m
A biotechnology company, focuses on unlocking the potential of its intellectual property.
CYAD
€0.29
7D
7.4%
1Y
-22.9%
Hyloris Pharmaceuticals
Market Cap: €125.7m
Operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.
HYL
€4.43
7D
-1.6%
1Y
-30.1%
Financière de Tubize
Market Cap: €8.2b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€185.60
7D
-3.0%
1Y
18.1%
Oxurion
Market Cap: €212.9k
A biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium.
OXUR
€0.0028
7D
7.7%
1Y
-88.8%
BioSenic
Market Cap: €1.3m
A biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.
BIOS
€0.002
7D
0%
1Y
-23.1%